Welcome to our dedicated page for Modular Med SEC filings (Ticker: MODD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how a pre-commercial insulin pump developer navigates FDA milestones, R&D spend, and capital raises can be daunting. Modular Medical’s 10-K alone intertwines clinical data with manufacturing risk disclosures, while urgent 8-Ks announce pivotal trial updates. If you’ve ever wondered “what does Modular Medical report in their SEC filings?” or searched for “where can I find the Modular Medical quarterly earnings report 10-Q filing,” you know the challenge. You need Modular Medical SEC filings explained simply.
Stock Titan solves this complexity. Our AI-powered engine turns dense documents into clear, digestible summaries. From Modular Medical annual report 10-K simplified sections on regulatory strategy to Modular Medical 8-K material events explained in minutes, you gain quick context. Interactive dashboards surface Modular Medical insider trading Form 4 transactions and deliver Modular Medical Form 4 insider transactions real-time, while concise charts spotlight trends found in each Modular Medical earnings report filing analysis. It’s understanding Modular Medical SEC documents with AI—without legalese.
Need to dive deeper? Use our real-time feed to:
- Monitor Modular Medical executive stock transactions Form 4 ahead of clinical milestones
- Compare incremental R&D outlays across every Modular Medical quarterly earnings report 10-Q filing
- Review Modular Medical proxy statement executive compensation details alongside peer med-tech firms
All filing types—10-K, 10-Q, 8-K, S-1, Forms 3 & 4—arrive seconds after EDGAR posts. Expert commentary highlights how pump design patents, FDA submissions, and financing rounds may impact valuation. With Stock Titan’s AI you save hours, focus on decisions, and stay ahead of the next disclosure.
Alyeska Investment Group, L.P., Alyeska Fund GP, LLC and Anand Parekh reported collective beneficial ownership of Modular Medical, Inc. common stock equal to 2,068,958 shares, representing 3.81% of the outstanding class based on 54,247,388 shares. The filing shows no sole voting or dispositive power; all voting and dispositive power is shared. An exhibit clarifies the holders directly own 1,548,125 shares and hold warrants to purchase 520,833 shares. The filing states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing control. Signatures for the filers are included.
FAQ
What is the current stock price of Modular Med (MODD)?
What is the market cap of Modular Med (MODD)?
